KMS Medisurgi Limited
Fundamental Score
KMS Medisurgi Limited Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of KMSMEDI across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Robust Profit Growth (340.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Excellent EPS Growth (31.95% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (31.95% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.11)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (7.10x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (74.42%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
7 factors identified
Below-Average Return on Equity (5.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.26%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 94.89x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Revenue Contraction (-9.06%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for KMS Medisurgi Limited
About KMSMEDI
Business Overview
KMS Medisurgi Limited engages in the manufacture and marketing of surgical equipment and wound care products in India, Dubai, Vietnam, Australia, Cambodia, Africa, Philippines, Russia, Pakistan, Europe, Bangladesh, and the United States. The company offers surgical tapes, such as medi, non-woven microporous surgical, surgical paper, transparent surgical, soft gel surgical, soft silicone, silk, and foam tapes, as well as adhesive tapes U.S.P and non woven surgical with acrylic adhesive; surgical dressing, including blister and corn plaster, non adherent foam dressing, non adherent silver dressing, non adherent island dressing, wide area fixation dressing, non woven IV dressing, transparent PU frame style dressing, transparent IV dressing, and hydrocolloid dressing; and theatre incise drape iodine and theatre incise drape. It also provides orthopaedic fiberglass cast; double side tape, foam tape for ECG electrodes, and incise film for drape construction eye drape; and athletic, kinesiology, and pet tape, as well as cohesive bandage. In addition, the company offers beauty products comprising acne patch, breast lift and fashion tape, earring support patch, eyeliner stencil, cannula fixation dressing with pad, frame style iv dressing, makeup shields, and makeup tape rolls. Further, it provides surgical disposables, haemostat and medical devices, as well as urology, surgery, orthopedic/physiotherapy, blood banking, and other surgical equipment. Additionally, the company manufacture and undertake job work of coating of various substrates. KMS Medisurgi Limited was incorporated in 1999 and is headquartered in Mumbai, India.
Company Details
Key Leadership
Corporate Events
KMSMEDI Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of KMS Medisurgi Limited (KMSMEDI)?
As of 02 Jan 2026, 04:17 pm IST, KMS Medisurgi Limited (KMSMEDI) is currently trading at ₹126.50. The stock has a market capitalization of ₹41.75 (Cr).
Is KMSMEDI share price Overvalued or Undervalued?
KMSMEDI is currently trading at a P/E ratio of 94.89x, compared to the industry average of 47.12x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the KMS Medisurgi Limited share price?
Key factors influencing KMSMEDI's price include its quarterly earnings growth (Sales Growth: -9.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is KMS Medisurgi Limited a good stock for long-term investment?
KMS Medisurgi Limited shows a 5-year Profit Growth of 31.95% and an ROE of 5.59%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.11 before investing.
How does KMS Medisurgi Limited compare with its industry peers?
KMS Medisurgi Limited competes with major peers in the Healthcare Equipment & Supplies. Investors should compare KMSMEDI's P/E of 94.89x and ROE of 5.59% against the industry averages to determine its competitive standing.
What is the P/E ratio of KMSMEDI and what does it mean?
KMSMEDI has a P/E ratio of 94.89x compared to the industry average of 47.12x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹95 for every ₹1 of annual earnings.
How is KMSMEDI performing according to Bull Run's analysis?
KMSMEDI has a Bull Run fundamental score of 43.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does KMSMEDI belong to?
KMSMEDI operates in the Healthcare Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting KMS Medisurgi Limited.
What is Return on Equity (ROE) and why is it important for KMSMEDI?
KMSMEDI has an ROE of 5.59%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently KMS Medisurgi Limited generates profits from shareholders' equity.
How is KMSMEDI's debt-to-equity ratio and what does it indicate?
KMSMEDI has a debt-to-equity ratio of 0.11, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is KMSMEDI's dividend yield and is it a good dividend stock?
KMSMEDI offers a dividend yield of 0.04%, which means you receive ₹0.04 annual dividend for every ₹100 invested.
How has KMSMEDI grown over the past 5 years?
KMSMEDI has achieved 5-year growth rates of: Sales Growth 6.16%, Profit Growth 31.95%, and EPS Growth 31.95%.
What is the promoter holding in KMSMEDI and why does it matter?
Promoters hold 74.42% of KMSMEDI shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is KMSMEDI's market capitalization category?
KMSMEDI has a market capitalization of ₹42 crores, placing it in the Small-cap category.
How volatile is KMSMEDI stock?
KMSMEDI has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for KMSMEDI?
KMSMEDI has a 52-week high of ₹N/A and low of ₹N/A.
What is KMSMEDI's operating profit margin trend?
KMSMEDI has a 5-year average Operating Profit Margin (OPM) of 6.69%, indicating the company's operational efficiency.
How is KMSMEDI's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -9.06% and YoY Profit Growth of 340.00%.
What is the institutional holding pattern in KMSMEDI?
KMSMEDI has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.